Nurses as adverse drug reaction reporting advocates

被引:1
作者
Schjott, Jan [1 ,2 ,3 ]
Pettersen, Trond R. [3 ,4 ]
Andreassen, Lillan Mo [1 ,2 ]
Bjanes, Tormod K. [2 ]
机构
[1] Haukeland Hosp, Reg Med Informat & Pharmacovigilance Ctr RELIS Ve, Jonas Lies Vei 91B, N-5021 Bergen, Norway
[2] Haukeland Hosp, Dept Clin Biochem & Pharmacol, Bergen, Norway
[3] Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway
[4] Haukeland Hosp, Dept Heart Dis, Bergen, Norway
关键词
Nurses; Adverse drug reactions; Training programme; Pharmacovigilance; Cardiovascular drugs; MEDICINE;
D O I
10.1093/eurjcn/zvac113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adverse drug reactions (ADRs) is a challenge in modern healthcare, particularly given the increasing complexity of drug therapy, an ageing population, rising multimorbidity, and a high patient turnover. The core activity of detecting potential ADRs over the last half century has been spontaneous reporting systems. A recent Norwegian regulation commits healthcare professionals other than physicians and dentists to report serious ADRs. In this discussion paper, we share our preliminary experience with a training programme using nurses as ADR advocates to stimulate ADR reporting among the clinical staff in a hospital department.
引用
收藏
页码:765 / 768
页数:4
相关论文
共 16 条
  • [1] A systematic review of hospitalization resulting from medicine-related problems in adult patients
    Al Hamid, Abdullah
    Ghaleb, Maisoon
    Aljadhey, Hisham
    Aslanpour, Zoe
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (02) : 202 - 217
  • [2] Antihypertensive-related adverse drug reactions among older hospitalized adults
    Alhawassi, Tariq M.
    Krass, Ines
    Pont, Lisa G.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (02) : 428 - 435
  • [3] Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: current status, challenges and the future
    Alomar, Muaed
    Tawfiq, Ali M.
    Hassan, Nageeb
    Palaian, Subish
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [4] [Anonymous], 2016, ANN NURS PRACT
  • [5] The key role of clinical and community health nurses in pharmacovigilance
    Bigi, Caterina
    Bocci, Guido
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (11) : 1379 - 1387
  • [6] Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
    Bouvy, Jacoline C.
    De Bruin, Marie L.
    Koopmanschap, Marc A.
    [J]. DRUG SAFETY, 2015, 38 (05) : 437 - 453
  • [7] Council for International Organizations of Medical Sciences, 2022, CIOMS CUM PHARM GLOS
  • [8] Factors that condition the spontaneous reporting of adverse drug reactions among nurses: an integrative review
    De Angelis, Alessia
    Colaceci, Sofia
    Giusti, Angela
    Vellone, Ercole
    Alvaro, Rosaria
    [J]. JOURNAL OF NURSING MANAGEMENT, 2016, 24 (02) : 151 - 163
  • [9] Under-reporting of adverse drug reactions - A systematic review
    Hazell, Lorna
    Shakir, Saad A. W.
    [J]. DRUG SAFETY, 2006, 29 (05) : 385 - 396
  • [10] The Costs of Adverse Drug Events in Community Hospitals
    Hug, Balthasar L.
    Keohane, Carol
    Seger, Diane L.
    Yoon, Catherine
    Bates, David W.
    [J]. JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2012, 38 (03) : 120 - 126